Tearsheet

UnitedHealth (UNH)

Market Price (10/30/2025): $355.1 | Market Cap: $321.7 Bil
Sector: Health Care | Industry: Managed Health Care

UnitedHealth (UNH)

Market Price (10/30/2025): $355.1
Market Cap: $321.7 Bil
Sector: Health Care
Industry: Managed Health Care

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow

0	Attractive yield Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 7.9%, Dividend Yield is 2.4%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 3.7%, FCF Yield is 5.4%	Weak multi-year price returns 2Y Excs Rtn is -95%, 3Y Excs Rtn is -112%
1	Valuation becoming less expensive P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -38%
2	Attractive cash flow generation CFO LTM is 21 Bil, FCF LTM is 17 Bil
3	Low stock price volatility Vol 12M is 48%

0	Attractive yield Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 7.9%, Dividend Yield is 2.4%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 3.7%, FCF Yield is 5.4%
1	Valuation becoming less expensive P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -38%
2	Attractive cash flow generation CFO LTM is 21 Bil, FCF LTM is 17 Bil
3	Low stock price volatility Vol 12M is 48%
4	Weak multi-year price returns 2Y Excs Rtn is -95%, 3Y Excs Rtn is -112%

Market Valuation & Key Metrics

Valuation
Key Metrics

	10/30/25	2024	2023	2022	2021
Share Price CYE	$355.10	$497.02	$509.30	$505.28	$472.50
Market Cap CYE ($ Bil)	321.7	456.3	469.6	471.9	444.2
Total Debt ($ Bil)	80.1	76.9	62.5	57.6	46.0
Total Cash ($ Bil)	30.6	29.1	29.6	27.9	23.9
Enterprise Value ($ Bil)	371.2	533.2	532.1	529.5	490.2
Valuation Ratios
P/S TTM	0.7	1.2	1.3	1.5	1.6
P/EBIT TTM	12.3	19.4	15.1	17.5	19.8
P/E TTM	18.3	32.3	21.8	24.7	27.4
Sector Ratios
P/S TTM (Sector)	4.1	3.5	4.0	4.5	7.3
P/EBIT TTM (Sector)	-1.7	-1.3	-1.4	-1.3	-2.7
P/E TTM (Sector)	-2.1	-1.5	-1.5	-1.3	-2.8

	10/30/25	2024	2023
Share Price CYE	$355.10	$497.02	$509.30
Market Cap CYE ($ Bil)	321.7	456.3	469.6
Total Debt ($ Bil)	80.1	76.9	62.5
Total Cash ($ Bil)	30.6	29.1	29.6
Enterprise Value ($ Bil)	371.2	533.2	532.1
Valuation Ratios
P/S TTM	0.7	1.2	1.3
P/EBIT TTM	12.3	19.4	15.1
P/E TTM	18.3	32.3	21.8
Sector Ratios
P/S TTM (Sector)	4.1	3.5	4.0
P/EBIT TTM (Sector)	-1.7	-1.3	-1.4
P/E TTM (Sector)	-2.1	-1.5	-1.5

	UNH	S&P 500
REVENUE GROWTH	GOOD
Rev LTM ($ Bil)	435.2
Rev Chg Q	12.2%	6.4%
Rev Chg LTM	10.5%	5.4%
Rev Chg 3Y Avg	11.4%	5.3%
PROFITABILITY	VERY POOR
Op Inc LTM ($ Bil)	26.4
CFO LTM ($ Bil)	21.0
Net Inc LTM ($ Bil)	17.6
Op Mgn LTM	6.1%	18.7%
CFO/Rev LTM	4.8%	20.4%
Net Inc Mgn	4.0%	12.8%
VALUATION	MODERATE
P/S	0.7	3.2
P/CFO	15.4	15.5
P/FCF	18.5	20.6
P/E	18.3	23.6
STABILITY	GOOD
Debt/Equity	0.25	0.21
Cash/Assets	0.10	0.07

UNH Stock

Return (1M):

Factor Drivers of Stock Movement

The 34.4% change in UNH stock from 7/30/2025 to 10/29/2025 was primarily driven by a 67.8% change in the company's P/E Multiple.

	7302025	10292025	Change
Stock Price ($)	264.37	355.26	34.38%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	410057.00	435159.00	6.12%
Net Income Margin (%)	5.39%	4.04%	-25.02%
P/E Multiple	10.91	18.30	67.78%
Shares Outstanding (Mil)	912.00	906.00	0.66%
Cumulative Contribution			34.37%

LTM = Last Twelve Months as of date shown

The -12.5% change in UNH stock from 4/30/2025 to 10/29/2025 was primarily driven by a -29.3% change in the company's P/E Multiple.

	4302025	10292025	Change
Stock Price ($)	405.98	355.26	-12.49%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	400278.00	435159.00	8.71%
Net Income Margin (%)	3.60%	4.04%	12.32%
P/E Multiple	25.87	18.30	-29.27%
Shares Outstanding (Mil)	918.00	906.00	1.31%
Cumulative Contribution			-12.51%

LTM = Last Twelve Months as of date shown

The -35.4% change in UNH stock from 10/29/2024 to 10/29/2025 was primarily driven by a -49.1% change in the company's P/E Multiple.

	10292024	10292025	Change
Stock Price ($)	550.20	355.26	-35.43%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	385439.00	435159.00	12.90%
Net Income Margin (%)	3.66%	4.04%	10.47%
P/E Multiple	35.93	18.30	-49.07%
Shares Outstanding (Mil)	921.00	906.00	1.63%
Cumulative Contribution			-35.45%

LTM = Last Twelve Months as of date shown

The -32.2% change in UNH stock from 10/30/2022 to 10/29/2025 was primarily driven by a -32.1% change in the company's Net Income Margin (%).

	10302022	10292025	Change
Stock Price ($)	523.74	355.26	-32.17%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	306561.00	435159.00	41.95%
Net Income Margin (%)	5.95%	4.04%	-32.12%
P/E Multiple	26.88	18.30	-31.93%
Shares Outstanding (Mil)	937.00	906.00	3.31%
Cumulative Contribution			-32.24%

LTM = Last Twelve Months as of date shown

Return vs. Risk

Price Returns Compared

	2020	2021	2022	2023	2024	2025	Total [1]
Returns
UNH Return	21%	45%	7%	1%	-2%	-29%	35%
Peers Return	12%	34%	11%	-6%	-26%	6%	23%
S&P 500 Return	16%	27%	-19%	24%	23%	17%	110%
Monthly Win Rates [3]
UNH Win Rate	58%	58%	42%	42%	50%	56%
Peers Win Rate	47%	55%	58%	47%	38%	53%
S&P 500 Win Rate	58%	75%	42%	67%	75%	67%
Max Drawdowns [4]
UNH Max Drawdown	-33%	-8%	-9%	-15%	-16%	-52%
Peers Max Drawdown	-31%	-5%	-14%	-24%	-30%	-25%
S&P 500 Max Drawdown	-31%	-1%	-25%	-1%	-2%	-15%

[1] Cumulative total returns since the beginning of 2020
[2] Peers: CVS, CI, HUM, CNC, MOH. See UNH Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 10/29/2025 (YTD)

How Low Can It Go

Unique Key	Event	UNH	S&P 500
2022 Inflation Shock	2022 Inflation Shock
2022 Inflation Shock% Loss	% Loss	-19.3%	-25.4%
2022 Inflation Shock% Gain to Breakeven	% Gain to Breakeven	24.0%	34.1%
2022 Inflation ShockTime to Breakeven	Time to Breakeven	370 days	464 days
2020 Covid Pandemic	2020 Covid Pandemic
2020 Covid Pandemic% Loss	% Loss	-36.2%	-33.9%
2020 Covid Pandemic% Gain to Breakeven	% Gain to Breakeven	56.7%	51.3%
2020 Covid PandemicTime to Breakeven	Time to Breakeven	70 days	148 days
2018 Correction	2018 Correction
2018 Correction% Loss	% Loss	-24.3%	-19.8%
2018 Correction% Gain to Breakeven	% Gain to Breakeven	32.0%	24.7%
2018 CorrectionTime to Breakeven	Time to Breakeven	243 days	120 days
2008 Global Financial Crisis	2008 Global Financial Crisis
2008 Global Financial Crisis% Loss	% Loss	-72.4%	-56.8%
2008 Global Financial Crisis% Gain to Breakeven	% Gain to Breakeven	261.9%	131.3%
2008 Global Financial CrisisTime to Breakeven	Time to Breakeven	1229 days	1480 days

Compare to CVS, CI, HUM, CNC, MOH

In The Past

UnitedHealth's stock fell -19.3% during the 2022 Inflation Shock from a high on 10/31/2022. A -19.3% loss requires a 24.0% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About UnitedHealth (UNH)

Business Description

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.

Interactive Breakdown

UnitedHealth Interactive Breakdown Analysis

Better Bets than UnitedHealth (UNH)

	UNH	Better Performance than UNH
Metric	Value	Industry (Managed Health Care)
Rev Chg LTM	10.5%	ELV (12.0%), CNC (14.9%), MOH (13.7%), HQY (15.4%), OSCR (48.3%)
Rev Chg 3Y Avg	11.4%	MOH (12.8%), HQY (16.9%), OSCR (52.3%), ALHC (34.5%), CLOV (2443.4%)
Op Mgn LTM	6.1%	HQY (21.6%)
CFO/Rev LTM	4.8%	HQY (28.9%), OSCR (11.5%)
FCF/Rev LTM	4.0%	HQY (24.7%), OSCR (11.2%)
Total Yield	7.9%	ELV (9.4%), MOH (10.5%)

	UNH	Better Performance than UNH
Metric	Value	Sector (Health Care)
Rev Chg LTM	10.5%	LLY (36.8%), ISRG (22.2%), AMGN (12.9%), BSX (21.4%), SYK (11.4%)
Rev Chg 3Y Avg	11.4%	LLY (23.4%), ISRG (16.3%), BSX (14.6%), MCK (12.2%), CI (13.2%)
Op Mgn LTM	6.1%	LLY (43.0%), JNJ (26.2%), ABBV (23.5%), MRK (31.2%), ABT (17.4%)
CFO/Rev LTM	4.8%	LLY (20.5%), JNJ (26.3%), ABBV (33.1%), MRK (29.1%), ABT (21.0%)
FCF/Rev LTM	4.0%	JNJ (20.3%), ABBV (31.3%), MRK (23.1%), ABT (15.7%), TMO (14.3%)
Total Yield	7.9%	JNJ (8.3%), MRK (11.2%), ABT (8.3%), PFE (13.0%), BMY (11.9%)

	UNH	Better Performance than UNH
Metric	Value	All Other Sectors
Rev Chg LTM	10.5%	NVDA (71.6%), MSFT (15.6%), GOOGL (13.1%), AMZN (10.9%), META (19.4%)
Rev Chg 3Y Avg	11.4%	NVDA (92.0%), MSFT (13.2%), META (13.0%), AVGO (24.0%), JPM (13.5%)
Op Mgn LTM	6.1%	NVDA (58.1%), MSFT (46.3%), AAPL (31.9%), GOOGL (32.7%), AMZN (11.4%)
CFO/Rev LTM	4.8%	NVDA (46.6%), MSFT (50.0%), AAPL (26.6%), GOOGL (36.0%), AMZN (18.1%)
FCF/Rev LTM	4.0%	NVDA (43.6%), MSFT (26.6%), AAPL (23.5%), GOOGL (18.0%), META (30.7%)
Total Yield	7.9%	XOM (9.6%), BABA (35.0%), WFC (9.3%), TM (2019.8%), CVX (9.5%)

		Best Bets In Health Care Sector
	UNH	RPRX	HALO	CPRX	LNTH	PBH	PFE	INCY	EW	ILMN	HCA
What You Pay
P/E	18.3	15.2	14.2	12.3	14.1	14.1	12.8	14.8	11.7	11.9	18.8
P/EBIT	12.3	8.0	11.2	10.5	9.7	9.0	10.3	11.1	29.0	9.9	10.2
What You Get
Rev Chg Q	12.2%	7.7%	40.8%	19.4%	-4.1%	-6.6%	10.3%	20.0%	11.9%	-4.8%	6.4%
Rev Chg LTM	10.5%	3.0%	35.0%	28.5%	5.7%	0.6%	13.5%	18.1%	9.1%	-3.3%	6.4%
Rev Chg 3Y Avg	11.4%	0.8%	35.5%	49.9%	34.3%	0.8%	-12.4%	13.1%	3.0%	-3.0%	6.6%
FCF/Rev 3Y Avg	4.9%	113.4%	43.4%	38.9%	26.1%	21.6%	13.8%	13.5%	11.9%	9.0%	8.4%

[1] Choosing top 10 best bets from each sector quarterly is an alpha producing strategy vs sector benchmark
[2] Historical annualized return of 11%, alpha of 1.9%, and sharpe of 0.52

Latest Trefis Analyses

	Title	Topic	Date
0	DASHBOARDS
1	UnitedHealth Earnings Notes
2	Why UnitedHealth Stock Jumped 30%?
3	With UnitedHealth Stock Climbed 6.6% In A Month, How Confident Are You?	Return
4	UNH Delivers $76 Bil to Shareholders Over the Last 10 Years
5	Should You Buy UnitedHealth Stock?	Buy or Fear
6	As UNH Surges 12% in a Day, LNG's Story Stands Out	Counter-Intuitive Comparisons
7	With UNH Up 12% in a Day, Is It Time to Compare It Against PTCT?	Counter-Intuitive Comparisons
8	Better Bet Than UNH Stock: Pay Less Than UnitedHealth To Get More From IBKR, JEF
9	Better Bet Than UNH Stock: Pay Less Than UnitedHealth To Get More From MOH, PTCT
10	Better Bet Than UNH Stock: Pay Less Than UnitedHealth To Get More From MOH
11	ARTICLES
12	UnitedHealth Stock Surged 30%, Here’s Why		October 23rd, 2025
13	UNH Has Returned $76 Bil To Shareholders In A Decade		October 4th, 2025
14	UNH Leaps 16% In One Month, Time To Buy The Stock?		September 26th, 2025
15	Why UnitedHealth Isn’t Done Yet		September 10th, 2025
16	S&P 500 Movers \| Winners: UNH, CNC, SMCI \| Losers: HUM, ALB, FOX		September 10th, 2025

	Title
0	DASHBOARDS
1	UnitedHealth Stock Surged 30%, Here’s Why
2	UNH Has Returned $76 Bil To Shareholders In A Decade
3	UNH Leaps 16% In One Month, Time To Buy The Stock?
4	Why UnitedHealth Isn’t Done Yet
5	S&P 500 Movers \| Winners: UNH, CNC, SMCI \| Losers: HUM, ALB, FOX
6	ARTICLES
7	UnitedHealth Earnings Notes
8	Why UnitedHealth Stock Jumped 30%?
9	With UnitedHealth Stock Climbed 6.6% In A Month, How Confident Are You?
10	UNH Delivers $76 Bil to Shareholders Over the Last 10 Years
11	Should You Buy UnitedHealth Stock?
12	As UNH Surges 12% in a Day, LNG's Story Stands Out
13	With UNH Up 12% in a Day, Is It Time to Compare It Against PTCT?
14	Better Bet Than UNH Stock: Pay Less Than UnitedHealth To Get More From IBKR, JEF
15	Better Bet Than UNH Stock: Pay Less Than UnitedHealth To Get More From MOH, PTCT
16	Better Bet Than UNH Stock: Pay Less Than UnitedHealth To Get More From MOH

Trade Ideas

Select past ideas related to UNH. For more, see Trefis Trade Ideas.

Unique Key	Date	Ticker	Company	Category	Trade Strategy	6M Fwd Rtn	12M Fwd Rtn	12M Max DD
ADMA_9302025_Dip_Buyer_ValueBuy	09302025	ADMA	ADMA Biologics	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	5.9%	5.9%	-4.6%
REGN_9302025_Dip_Buyer_ValueBuy	09302025	REGN	Regeneron Pharmaceuticals	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	16.1%	16.1%	-0.8%
HAE_9262025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG	09262025	HAE	Haemonetics	Dip Buy	DB \| FCF Yield \| Low D/EDip Buy with High Free Cash Flow Yield Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap	2.6%	2.6%	-0.1%
WAT_9192025_Monopoly_xInd_xCD_Getting_Cheaper	09192025	WAT	Waters	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	14.2%	14.2%	-4.3%
ISRG_9052025_Monopoly_xInd_xCD_Getting_Cheaper	09052025	ISRG	Intuitive Surgical	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	15.2%	15.2%	-8.0%
UNH_5312025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG	05312025	UNH	UnitedHealth	Dip Buy	DB \| FCF Yield \| Low D/EDip Buy with High Free Cash Flow Yield Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap	19.3%	19.3%	-20.7%

Unique Key	Date	Ticker	Company	Category	Trade Strategy	6M Fwd Rtn	12M Fwd Rtn	12M Max DD
ADMA_9302025_Dip_Buyer_ValueBuy	09302025	ADMA	ADMA Biologics	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	5.9%	5.9%	-4.6%
REGN_9302025_Dip_Buyer_ValueBuy	09302025	REGN	Regeneron Pharmaceuticals	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	16.1%	16.1%	-0.8%
HAE_9262025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG	09262025	HAE	Haemonetics	Dip Buy	DB \| FCF Yield \| Low D/EDip Buy with High Free Cash Flow Yield Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap	2.6%	2.6%	-0.1%
WAT_9192025_Monopoly_xInd_xCD_Getting_Cheaper	09192025	WAT	Waters	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	14.2%	14.2%	-4.3%
ISRG_9052025_Monopoly_xInd_xCD_Getting_Cheaper	09052025	ISRG	Intuitive Surgical	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	15.2%	15.2%	-8.0%
UNH_5312025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG	05312025	UNH	UnitedHealth	Dip Buy	DB \| FCF Yield \| Low D/EDip Buy with High Free Cash Flow Yield Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap	19.3%	19.3%	-20.7%

Recent Active Movers

1 Day Top Gainers

#	Ticker	Company	1D Rtn	YTD Rtn
1	PUMP	ProPetro	52.1%	19.0%
2	FLS	Flowserve	30.9%	21.3%
3	ACDC	ProFrac	24.1%	-30.4%
4	AXGN	Axogen	23.1%	35.0%
5	TER	Teradyne	20.5%	38.6%
6	STX	Seagate Technology	19.1%	212.9%
7	MIR	Mirion Technologies	18.1%	70.5%
8	BE	Bloom Energy	18.0%	502.0%
9	AESI	Atlas Energy Solutions	16.7%	-42.6%
10	SNDK	SanDisk	16.4%

1 Day Top Losers

#	Ticker	Company	1D Rtn	YTD Rtn
1	LRN	Stride	-54.4%	-32.6%
2	VRNS	Varonis Systems	-48.7%	-27.2%
3	FI	Fiserv	-44.0%	-65.6%
4	AKBA	Akebia Therapeutics	-32.0%	10.5%
5	CWH	Camping World	-24.8%	-38.7%
6	AVTR	Avantor	-23.2%	-45.0%
7	PMI	Picard Medical	-19.0%	5106.3%
8	GIC	Global Industrial	-18.1%	19.3%
9	MNRO	Monro	-16.6%	-36.1%
10	EXTR	Extreme Networks	-15.3%	7.6%

1 Week Top Gainers

#	Ticker	Company	1W Rtn	YTD Rtn
1	INBX	Inhibrx Biosciences	144.4%	400.3%
2	PUMP	ProPetro	92.4%	19.0%
3	LUMN	Lumen Technologies	56.2%	107.2%
4	RNA	Avidity Biosciences	48.6%	139.5%
5	DYN	Dyne Therapeutics	44.5%	0.3%
6	ACDC	ProFrac	42.1%	-30.4%
7	BE	Bloom Energy	41.7%	502.0%
8	SNDK	SanDisk	39.1%
9	GTX	Garrett Motion	36.5%	92.3%
10	LITE	Lumentum	35.6%	155.2%

1 Week Top Losers

#	Ticker	Company	1W Rtn	YTD Rtn
1	PMI	Picard Medical	-75.1%	5106.3%
2	LRN	Stride	-54.1%	-32.6%
3	VRNS	Varonis Systems	-47.2%	-27.2%
4	NTLA	Intellia Therapeutics	-46.6%	12.5%
5	FI	Fiserv	-43.6%	-65.6%
6	ITGR	Integer	-40.2%	-50.7%
7	UAMY	United States Antimony	-35.9%	374.6%
8	AKBA	Akebia Therapeutics	-29.8%	10.5%
9	OGN	Organon	-29.1%	-56.5%
10	METC	Ramaco Resources	-27.2%	186.6%

1 Month Top Gainers

#	Ticker	Company	1M Rtn	YTD Rtn
1	PRAX	Praxis Precision Medicines	269.4%	154.4%
2	INBX	Inhibrx Biosciences	128.8%	400.3%
3	PUMP	ProPetro	111.8%	19.0%
4	NVTS	Navitas Semiconductor	88.0%	280.1%
5	FLNC	Fluence Energy	87.8%	27.7%
6	DYN	Dyne Therapeutics	86.8%	0.3%
7	VICR	Vicor	83.4%	88.7%
8	SNDK	SanDisk	82.1%
9	LUMN	Lumen Technologies	79.7%	107.2%
10	GLUE	Monte Rosa Therapeutics	68.7%	80.1%

1 Month Top Losers

#	Ticker	Company	1M Rtn	YTD Rtn
1	PMI	Picard Medical	-61.4%	5106.3%
2	LRN	Stride	-53.0%	-32.6%
3	FI	Fiserv	-45.2%	-65.6%
4	VRNS	Varonis Systems	-43.7%	-27.2%
5	OGN	Organon	-40.6%	-56.5%
6	NFE	New Fortress Energy	-40.3%	-91.3%
7	VG	Venture Global	-38.0%
8	ITGR	Integer	-36.8%	-50.7%
9	LENZ	LENZ Therapeutics	-34.2%	6.1%
10	CZR	Caesars Entertainment	-30.7%	-44.0%

Recent Active Movers

1 Day Top Gainers

#	Ticker	Company	1D Rtn	YTD Rtn
1	PUMP	ProPetro	52.1%	19.0%
2	FLS	Flowserve	30.9%	21.3%
3	ACDC	ProFrac	24.1%	-30.4%
4	AXGN	Axogen	23.1%	35.0%
5	TER	Teradyne	20.5%	38.6%
6	STX	Seagate Technology	19.1%	212.9%
7	MIR	Mirion Technologies	18.1%	70.5%
8	BE	Bloom Energy	18.0%	502.0%
9	AESI	Atlas Energy Solutions	16.7%	-42.6%
10	SNDK	SanDisk	16.4%

1 Day Top Losers

#	Ticker	Company	1D Rtn	YTD Rtn
1	LRN	Stride	-54.4%	-32.6%
2	VRNS	Varonis Systems	-48.7%	-27.2%
3	FI	Fiserv	-44.0%	-65.6%
4	AKBA	Akebia Therapeutics	-32.0%	10.5%
5	CWH	Camping World	-24.8%	-38.7%
6	AVTR	Avantor	-23.2%	-45.0%
7	PMI	Picard Medical	-19.0%	5106.3%
8	GIC	Global Industrial	-18.1%	19.3%
9	MNRO	Monro	-16.6%	-36.1%
10	EXTR	Extreme Networks	-15.3%	7.6%

1 Week Top Gainers

#	Ticker	Company	1W Rtn	YTD Rtn
1	INBX	Inhibrx Biosciences	144.4%	400.3%
2	PUMP	ProPetro	92.4%	19.0%
3	LUMN	Lumen Technologies	56.2%	107.2%
4	RNA	Avidity Biosciences	48.6%	139.5%
5	DYN	Dyne Therapeutics	44.5%	0.3%
6	ACDC	ProFrac	42.1%	-30.4%
7	BE	Bloom Energy	41.7%	502.0%
8	SNDK	SanDisk	39.1%
9	GTX	Garrett Motion	36.5%	92.3%
10	LITE	Lumentum	35.6%	155.2%

1 Week Top Losers

#	Ticker	Company	1W Rtn	YTD Rtn
1	PMI	Picard Medical	-75.1%	5106.3%
2	LRN	Stride	-54.1%	-32.6%
3	VRNS	Varonis Systems	-47.2%	-27.2%
4	NTLA	Intellia Therapeutics	-46.6%	12.5%
5	FI	Fiserv	-43.6%	-65.6%
6	ITGR	Integer	-40.2%	-50.7%
7	UAMY	United States Antimony	-35.9%	374.6%
8	AKBA	Akebia Therapeutics	-29.8%	10.5%
9	OGN	Organon	-29.1%	-56.5%
10	METC	Ramaco Resources	-27.2%	186.6%

Peer Comparisons for UnitedHealth

Financials

	UNH	CVS	CI	HUM	CNC	MOH	Median
Name	UnitedHe.	CVS Heal.	Cigna	Humana	Centene	Molina H.
Mkt Price	355.26	80.60	299.12	292.67	37.34	160.28	226.48
Mkt Cap	321.9	102.3	81.0	35.3	18.3	8.4	58.1
Rev LTM	435,159	394,084	254,465	123,110	185,857	44,550	220,161
Op Inc LTM	26,357	10,751	-	-	1,095	1,323	6,037
FCF LTM	17,372	6,293	6,010	2,439	3,356	-574	4,683
FCF 3Y Avg	18,968	6,427	8,803	3,175	3,017	519	4,801
CFO LTM	20,958	9,109	7,443	2,932	4,064	-461	5,754
CFO 3Y Avg	22,443	9,277	10,241	3,958	3,761	619	6,618

Growth & Margins

	UNH	CVS	CI	HUM	CNC	MOH	Median
Name	UnitedHe.	CVS Heal.	Cigna	Humana	Centene	Molina H.
Rev Chg LTM	10.5%	6.8%	24.6%	9.9%	14.9%	13.7%	12.1%
Rev Chg 3Y Avg	11.4%	7.7%	13.2%	11.3%	9.6%	12.8%	11.3%
Rev Chg Q	12.2%	7.8%	18.2%	9.6%	18.2%	11.0%	11.6%
QoQ Delta Rev Chg LTM	2.9%	1.9%	4.1%	2.4%	4.3%	2.6%	2.8%
Op Mgn LTM	6.1%	2.7%	-	-	0.6%	3.0%	2.8%
Op Mgn 3Y Avg	7.7%	3.3%	-	-	1.7%	4.0%	3.6%
QoQ Delta Op Mgn LTM	-1.2%	0.1%	-	-	-0.5%	-0.8%	-0.7%
CFO/Rev LTM	4.8%	2.3%	2.9%	2.4%	2.2%	-1.0%	2.3%
CFO/Rev 3Y Avg	5.8%	2.5%	5.0%	4.0%	2.3%	2.0%	3.3%
FCF/Rev LTM	4.0%	1.6%	2.4%	2.0%	1.8%	-1.3%	1.9%
FCF/Rev 3Y Avg	4.9%	1.8%	4.3%	3.3%	1.9%	1.7%	2.6%

Valuation

	UNH	CVS	CI	HUM	CNC	MOH	Median
Name	UnitedHe.	CVS Heal.	Cigna	Humana	Centene	Molina H.
Mkt Cap	321.9	102.3	81.0	35.3	18.3	8.4	58.1
P/S	0.7	0.3	0.3	0.3	0.1	0.2	0.3
P/EBIT	12.3	17.1	9.7	12.3	-4.4	6.4	11.0
P/E	18.3	218.1	16.1	22.4	-3.5	9.5	17.2
P/CFO	15.4	11.2	10.9	12.0	4.5	-18.3	11.1
Total Yield	7.9%	3.8%	8.2%	5.7%	-28.8%	10.5%	6.8%
Dividend Yield	2.4%	3.3%	1.9%	1.2%	0.0%	0.0%	1.6%
FCF Yield 3Y Avg	4.5%	7.1%	9.9%	6.3%	11.5%	1.8%	6.7%
D/E	0.2	0.8	0.4	0.4	1.0	0.5	0.4
Net D/E	0.2	0.7	0.3	-0.3	-0.1	-0.5	0.0

Returns

	UNH	CVS	CI	HUM	CNC	MOH	Median
Name	UnitedHe.	CVS Heal.	Cigna	Humana	Centene	Molina H.
1M Rtn	2.9%	7.5%	4.4%	14.7%	6.0%	-16.9%	5.2%
3M Rtn	34.4%	30.4%	0.9%	12.3%	44.8%	0.2%	21.4%
6M Rtn	-12.5%	23.1%	-11.2%	12.4%	-37.6%	-51.0%	-11.8%
12M Rtn	-35.4%	49.4%	-1.1%	15.1%	-38.4%	-50.4%	-18.3%
3Y Rtn	-32.2%	-4.0%	-2.9%	-45.6%	-56.5%	-54.8%	-38.9%
1M Excs Rtn	-0.1%	4.8%	0.7%	9.5%	1.6%	-19.3%	1.2%
3M Excs Rtn	34.6%	22.2%	3.7%	8.8%	34.5%	-7.2%	15.5%
6M Excs Rtn	-36.2%	-0.6%	-34.9%	-11.3%	-61.3%	-74.7%	-35.6%
12M Excs Rtn	-54.3%	30.1%	-22.4%	-4.8%	-60.5%	-69.4%	-38.4%
3Y Excs Rtn	-112.4%	-86.1%	-78.7%	-123.6%	-132.2%	-137.5%	-118.0%

Comparison Analyses

	Title
0	UNH Looks Stronger Than CVS With 48% Return Potential
1	UnitedHealth Group vs. Walmart: With Return Forecast Of 13%, UnitedHealth Group Is A Better Bet
2	With 48% Gains On The Table, UNH May Outshine HCA
3	HUM or UNH - With 48% Return Forecast, UNH Probably Deserves Your Money
4	UnitedHealth Group vs. Molina Healthcare: With Return Forecast Of 13%, UnitedHealth Group Is A Better Bet
5	UNH or CI - With 52% Return Forecast, CI Probably Deserves Your Money
6	With 46% Gains On The Table, UNH May Outshine CVX
7	UnitedHealth Group vs. Home Depot: Both Seem Similar Bets
8	PFE or UNH - With 46% Return Forecast, UNH Probably Deserves Your Money
9	UnitedHealth Group vs. Walmart: Neither Seems Like A Good Bet

Financials

Annual
Quarterly

$ Mil \| FY: 12/31	LTM	2024	2023	2022	2021	2020	2019
Period End	9/30/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Filing Date	10/28/2025	2/27/2025	2/28/2024	2/24/2023	2/15/2022	3/1/2021	2/14/2020
Key Financials
Total Revenue	435,159	400,278	371,622	324,162	287,597	257,141	242,155
EBITDA	30,524	28,076	36,330	31,835	27,073	25,296	22,405
Operating Income	26,357	32,287	32,358	28,435	23,970	22,405	19,685
Net Income	17,589	14,405	22,381	20,120	17,285	15,403	13,839
EPS	19.31	15.64	24.12	21.47	18.33	16.23	14.55
Growth Rates
Total Revenue Growth	10.5%	7.7%	14.6%	12.7%	11.8%	6.2%	7.0%
EBITDA Growth	9.4%	-22.7%	14.1%	17.6%	7.0%	12.9%	13.3%
Operating Income Growth	-18.2%	-0.2%	13.8%	18.6%	7.0%	13.8%	13.5%
Net Income Growth	22.9%	-35.6%	11.2%	16.4%	12.2%	11.3%	15.5%
Margins
EBITDA Margin	7.0%	7.0%	9.8%	9.8%	9.4%	9.8%	9.3%
Operating Income Margin	6.1%	8.1%	8.7%	8.8%	8.3%	8.7%	8.1%
Net Income Margin	4.0%	3.6%	6.0%	6.2%	6.0%	6.0%	5.7%
Cash & Debt
Total Cash	30,614	29,113	29,628	27,911	23,907	19,781	14,245
Total Debt	80,136	76,904	62,537	57,623	46,003	43,467	40,678
Net Debt / (Cash)	49,522	47,791	32,909	29,712	22,096	23,686	26,433
Cash Flows
Net Cash from Operations	20,958	24,204	29,068	26,206	22,343	22,174	18,463
Free Cash from Operations	17,372	20,705	25,682	23,404	19,889	20,123	16,392
Returns to Shareholders
Dividends	7,846	7,533	6,761	5,991	5,280	4,584	3,932
Share Repurchases	10,517	9,000	8,000	7,000	5,000	4,250	5,500

$ Mil \| FY: 12/31	2025Q3	2025Q2	2025Q1	2024Q4	2024Q3	2024Q2	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4
Period End	9/30/2025	6/30/2025	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022
Filing Date	10/28/2025	8/11/2025	5/7/2025	2/27/2025	11/4/2024	8/9/2024	5/9/2024	2/28/2024	11/6/2023	8/2/2023	5/3/2023	2/24/2023
Key Financials Quarterly
Total Revenue	113,161	111,616	109,575	100,807	100,820	98,855	99,796	94,427	92,361	92,903	91,931	82,787
Ebitda	5,331	6,193	10,165	8,835	9,729	7,670	1,842	8,663	9,533	9,078	9,056	7,873
Operating Income	4,315	5,150	9,119	7,773	8,708	7,875	7,931	7,689	8,526	8,057	8,086	6,891
Net Income	2,348	3,406	6,292	5,543	6,055	4,216	-1,409	5,455	5,841	5,474	5,611	4,761
EPS	2.59	3.76	6.90	6.06	6.56	4.58	-1.53	5.90	6.31	5.89	6.01	5.10
Key Financials TTM
Total Revenue TTM	435,159	422,818	410,057	400,278	393,898	385,439	379,487	371,622	359,982	348,515	335,944	324,162
Ebitda TTM	30,524	34,922	36,399	28,076	27,904	27,708	29,116	36,330	35,540	34,297	33,153	31,835
Operating Income TTM	26,357	30,750	33,475	32,287	32,203	32,021	32,203	32,358	31,560	30,496	29,571	28,435
Net Income TTM	17,589	21,296	22,106	14,405	14,317	14,103	15,361	22,381	21,687	21,108	20,704	20,120
Growth Rates Quarterly
Total Revenue Growth	12.2%	12.9%	9.8%	6.8%	9.2%	6.4%	8.6%	14.1%	14.2%	15.6%	14.7%	12.3%
EBITDA Growth	-45.2%	-19.3%	451.8%	2.0%	2.1%	-15.5%	-79.7%	10.0%	15.0%	14.4%	17.0%	24.7%
Operating Income Growth	-50.4%	-34.6%	15.0%	1.1%	2.1%	-2.3%	-1.9%	11.6%	14.3%	13.0%	16.3%	24.4%
Net Income Growth	-61.2%	-19.2%	546.6%	1.6%	3.7%	-23.0%	-125.1%	14.6%	11.0%	8.0%	11.6%	16.9%
Margins Quarterly
EBITDA Margin	4.7%	5.5%	9.3%	8.8%	9.6%	7.8%	1.8%	9.2%	10.3%	9.8%	9.9%	9.5%
Operating Income Margin	3.8%	4.6%	8.3%	7.7%	8.6%	8.0%	7.9%	8.1%	9.2%	8.7%	8.8%	8.3%
Net Income Margin	2.1%	3.1%	5.7%	5.5%	6.0%	4.3%	-1.4%	5.8%	6.3%	5.9%	6.1%	5.8%
Cash & Debt
Total Cash	30,614	32,020	34,291	29,113	37,134	31,323	32,710	29,628	44,097	46,279	46,497	27,911
Total Debt	80,136	79,193	81,271	76,904	78,010	75,098	73,637	62,537	63,369	65,589	70,588	57,623
Net Debt / (Cash)	49,522	47,173	46,980	47,791	40,876	43,775	40,927	32,909	19,272	19,310	24,091	29,712
Cash Flows Quarterly
FCF from Operations	5,945	7,188	5,456	2,369	13,945	6,746	1,144	-5,193	6,902	11,032	16,327	-4,533
Cash Flows TTM
FCF from Operations TTM	20,958	28,958	28,516	24,204	16,642	9,599	13,885	29,068	29,728	41,375	37,214	26,206
Returns to Shareholders Quarterly
Dividends	2,002	2,000	1,912	1,932	1,937	1,935	1,729	1,738	1,739	1,747	1,537	1,541
Share Repurchases	-0	2,545	3,000	4,972	956	-0	3,072	1,500	1,500	3,000	2,000	1,000
Return on Invested Capital (ROIC) Quarterly
ROIC	27.4%	38.2%	62.0%	55.4%	70.0%	56.2%	77.5%	77.3%	138.9%	130.6%	105.7%	73.3%
Return on Invested Capital (ROIC) TTM
ROIC TTM	44.0%	54.1%	58.0%	51.3%	59.2%	54.0%	58.3%	78.2%	128.7%	123.8%	96.1%	75.0%

Segment Financials

Revenue by Segment

$ Mil	2024	2023	2022	2021	2020
UnitedHealthcare	281,360	249,741	222,899	200,875	193,842
Optum Rx	116,087	99,773	35,535	35,078	32,195
Optum Health	95,319	71,174	24,831	17,327	12,351
Optum Insight	18,932	14,581	4,332	3,861	3,767
Optum Eliminations	-3,703	-2,760
Corporate and Eliminations	-136,373	-108,347
Total	371,622	324,162	287,597	257,141	242,155

Operating Income by Segment

$ Mil	2024	2023	2022	2021	2020
UnitedHealthcare	16,415	14,379	11,975	12,359	10,326
Optum Health	6,560	6,032	4,462	3,434	2,963
Optum Rx	5,115	4,436	4,135	3,887	3,902
Optum Insight	4,268	3,588	3,398	2,725	2,494
Corporate and Eliminations	0	0
Optum Eliminations	0	0
Total	32,358	28,435	23,970	22,405	19,685

Assets by Segment

$ Mil	2024	2023	2022	2021	2020
UnitedHealthcare	110,943	107,094	102,967	98,229	88,250
Optum Health	89,432	68,950	60,474	52,073	40,444
Optum Rx	51,266	47,476	40,181	39,280	36,346
Optum Insight	34,173	31,090	16,868	15,425	15,181
Optum Eliminations	0	0
Corporate and Eliminations	-12,094	-8,905	-8,284	-7,718	-6,332
Total	273,720	245,705	212,206	197,289	173,889

Price Behavior

Price Behavior

Market Price	$355.26
Market Cap ($ Bil)	322.2
First Trading Date	03/26/1990
Distance from 52W High	-41.9%
	50 Days	200 Days
DMA Price	$341.35	$384.25
DMA Trend	down	up
Distance from DMA	4.1%	-7.5%
	3M	1YR
Volatility	41.2%	48.6%
Downside Capture	-25.77	37.36
Upside Capture	126.90	-11.89
Correlation (SPY)	27.5%	11.3%

UNH Betas & Captures as of 9/30/2025

	1M	2M	3M	6M	1Y	3Y
Beta	0.31	0.66	0.87	0.22	0.27	0.27
Up Beta	-3.10	0.24	1.18	0.51	0.52	0.47
Down Beta	-0.94	2.99	2.88	0.17	0.02	0.18
Up Capture	194%	167%	51%	-38%	-7%	2%
Bmk +ve Days	13	23	35	74	144	420
Stock +ve Days	12	24	34	62	128	390
Down Capture	-14%	-181%	-14%	15%	55%	49%
Bmk -ve Days	8	19	29	52	107	330
Stock -ve Days	9	18	30	64	123	361

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date	10152025
Short Interest: Shares Quantity	13,531,383
Short Interest: % Change Since 9302025	2.6%
Average Daily Volume	8,623,296
Days-to-Cover Short Interest	1.57
Basic Shares Quantity	906,000,000
Short % of Basic Shares	1.5%

Returns Analyses

	Title
0	With UnitedHealth Stock Climbed 6.6% In A Month, How Confident Are You?
1	UNH YTD Stock Return Of 2.9% Outperforms CNC by 2.9% and Underperforms CVS by -49%
2	UnitedHealth During 2008 Recession vs. 2022 Inflation Shock: UNH Stock Has 46% Upside If It Recovers To Pre-Inflation Shock Levels
3	UNH YTD Stock Return Of 8.3% Outperforms HCA by 23% and Underperforms CI by -18%
4	UnitedHealth Group Stock Return Comparison
5	[10/8/2021] UnitedHealth Group (UNH) Stock Price Forecast: AI Forecasts UNH Stock Price To Be Around $407 In A Month (Up 0.7%)
6	UnitedHealth Total Shareholder Return (TSR): 0.7% in 2023 and 15.9% 3-yr returns (below peer average)

Earnings Returns History

Expand for More

	Forward Returns
Earnings Date	1D Returns	5D Returns	21D Returns
10/28/2025	0.5%
7/29/2025	-7.5%	-14.6%	6.5%
4/17/2025	-22.4%	-27.5%	-50.1%
1/16/2025	-6.0%	-2.5%	-3.7%
10/15/2024	-8.1%	-5.6%	1.5%
7/16/2024	6.5%	8.4%	11.4%
4/16/2024	5.2%	10.2%	15.3%
1/12/2024	-3.4%	-6.7%	-4.1%
...
SUMMARY STATS
# Positive	13	11	15
# Negative	11	13	9
Median Positive	3.8%	4.3%	6.1%
Median Negative	-2.9%	-2.5%	-5.4%
Max Positive	7.2%	12.6%	15.3%
Max Negative	-22.4%	-27.5%	-50.1%

	Forward Returns
10/28/2025	0.5%
7/29/2025	-7.5%	-14.6%	6.5%
4/17/2025	-22.4%	-27.5%	-50.1%
1/16/2025	-6.0%	-2.5%	-3.7%
10/15/2024	-8.1%	-5.6%	1.5%
7/16/2024	6.5%	8.4%	11.4%
4/16/2024	5.2%	10.2%	15.3%
1/12/2024	-3.4%	-6.7%	-4.1%
10/13/2023	2.6%	1.2%	3.0%
7/14/2023	7.2%	12.6%	13.5%
4/14/2023	-2.7%	-7.4%	-6.7%
1/13/2023	-1.2%	-1.8%	-0.1%
10/14/2022	0.6%	2.2%	2.4%
7/15/2022	5.4%	4.0%	8.2%
4/14/2022	-0.4%	0.1%	-9.6%
1/19/2022	0.3%	-0.9%	4.1%
10/14/2021	4.2%	7.8%	13.3%
7/15/2021	1.3%	-0.0%	-2.1%
4/15/2021	3.8%	6.2%	8.8%
1/20/2021	-0.4%	-2.6%	-6.8%
10/14/2020	-2.9%	-2.4%	6.1%
7/15/2020	-1.4%	-1.1%	4.5%
4/15/2020	4.1%	1.4%	2.8%
1/15/2020	2.8%	4.3%	4.8%
SUMMARY STATS
# Positive	13	11	15
# Negative	11	13	9
Median Positive	3.8%	4.3%	6.1%
Median Negative	-2.9%	-2.5%	-5.4%
Max Positive	7.2%	12.6%	15.3%
Max Negative	-22.4%	-27.5%	-50.1%

SEC Filings

Expand for More

Report Date	Filing Date	Filing
9302025	10282025	10-Q 9/30/2025
6302025	8112025	10-Q 6/30/2025
3312025	5072025	10-Q 3/31/2025
12312024	2272025	10-K 12/31/2024
9302024	11042024	10-Q 9/30/2024
6302024	8092024	10-Q 6/30/2024
3312024	5092024	10-Q 3/31/2024
12312023	2282024	10-K 12/31/2023
9302023	11062023	10-Q 9/30/2023
6302023	8022023	10-Q 6/30/2023
3312023	5032023	10-Q 3/31/2023
12312022	2242023	10-K 12/31/2022
9302022	11022022	10-Q 9/30/2022
6302022	8032022	10-Q 6/30/2022
3312022	5042022	10-Q 3/31/2022
12312021	2152022	10-K 12/31/2021

Insider Activity

Expand for More

	Owner	Title	Filing Date	Action	Price	Shares	Transacted Value	Value of Held Shares	Form
0	Baker Charles D.		9152025	Sell	356.05	27	9,613		Form
1	Conway Patrick Hugh	Chief Executive Officer, Optum	6122025	Sell	305.00	589	179,645	3,171,528	Form
2	REX JOHN F	President & CFO	5162025	Buy	291.12	17,175	4,999,919	59,328,308	Form
3	HEMSLEY STEPHEN J	CEO, UHG	5162025	Buy	288.57	86,700	25,019,019	196,081,278	Form
4	FLYNN TIMOTHY PATRICK		5162025	Buy	320.80	1,533	491,786	1,935,386	Form

Industry Resources

Health Care Resources

U.S. National Library of Medicine

Health Data Management

FDA Tracker

External Quote Links

0	Y Finance	Barrons
1	TradingView	Morningstar
2	SeekingAlpha	ValueLine
3	Motley Fool	Robinhood
4	CNBC	Etrade
5	MarketWatch	Unusual Whales
6	YCharts	Perplexity Finance
7	FinViz

Prefer one of these to Trefis? Tell us why.

UnitedHealth (UNH)

Market Price (10/30/2025): $355.1 | Market Cap: $321.7 BilSector: Health Care | Industry: Managed Health Care

UnitedHealth (UNH)

Market Price (10/30/2025): $355.1Market Cap: $321.7 BilSector: Health CareIndustry: Managed Health Care

Market Valuation & Key Metrics

UNH Stock

Return vs. Risk

Price Returns Compared

How Low Can It Go

In The Past

Preserve Wealth

Asset Allocation

About UnitedHealth (UNH)

Interactive Breakdown

Better Bets than UnitedHealth (UNH)

Latest Trefis Analyses

Trade Ideas

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

1 Month Top Gainers

1 Month Top Losers

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for UnitedHealth

Financials

Growth & Margins

Valuation

Returns

Comparison Analyses

FDIC Bank Data

Bank Capital

Bank Deposits

Bank Assets

Bank Loans

Financials

Segment Financials

Price Behavior

Short Interest

Returns Analyses

Earnings Returns History

SEC Filings

Insider Activity

Industry Resources

External Quote Links

Market Price (10/30/2025): $355.1 | Market Cap: $321.7 Bil
Sector: Health Care | Industry: Managed Health Care

Market Price (10/30/2025): $355.1
Market Cap: $321.7 Bil
Sector: Health Care
Industry: Managed Health Care